Skip Navigation
Skip to contents

JPTM : Journal of Pathology and Translational Medicine


Author index

Page Path
HOME > Articles and issues > Author index
Asmaa Gaber Abdou 1 Article
Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo
Asmaa Gaber Abdou, Alaa Maraee, Hossam Yassien, Mona Sarhan
J Pathol Transl Med. 2018;52(6):363-368.   Published online October 23, 2018
  • 8,091 View
  • 179 Download
  • 9 Citations
AbstractAbstract PDF
Vitiligo is a chronic autoimmune disease in which the destruction of melanocytes causes white spots on the affected skin. Janus kinase (JAK) is a family of intracellular, non-receptor tyrosine kinases that transduce cytokine-mediated signals via the JAK–signal transducer and activator of transcription pathway. The aim of the present study is to explore the possible role of JAK1 in the pathogenesis of vitiligo using immunohistochemical methods.
The current study was conducted in a sample of 39 patients who presented with vitiligo and 22 healthy individuals who were age and sex matched as a control group. We used immunohistochemistry to evaluate JAK1 status (intensity and distribution) and assess the percentage of residual melanocytes using human melanoma black 45 (HMB45).
Intense and diffuse JAK1 expression was significantly more likely to indicate vitiliginous skin compared to normal skin (p < .001). Strong and diffuse JAK1 expression was associated with short disease duration, female sex, and lower percentage of melanocytes (detected by HMB45) (p < .05).
JAK1 may be involved in the pathogenesis of vitiligo, as indicated by intense and diffuse expression compared to control and association with lower percentage of melanocytes detected by HMB45 immunostaining.


Citations to this article as recorded by  
  • Signaling pathways in rheumatoid arthritis: implications for targeted therapy
    Qian Ding, Wei Hu, Ran Wang, Qinyan Yang, Menglin Zhu, Meng Li, Jianghong Cai, Peter Rose, Jianchun Mao, Yi Zhun Zhu
    Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
  • Acid-responsive PEGylated branching PLGA nanoparticles integrated into dissolving microneedles enhance local treatment of arthritis
    Hongmei Hu, Hang Ruan, Shuyao Ruan, Lixia Pei, Qian Jing, Tong Wu, Xiaolin Hou, Hao Xu, Youjie Wang, Nianping Feng, Yongtai Zhang
    Chemical Engineering Journal.2022; 431: 134196.     CrossRef
  • The skin delivery of tofacitinib citrate using transethosomes and hybridized ethosomes/nanostructured lipid carriers for vitiligo therapy: Dermatopharmacokinetics and in vivo assays
    Heba Hesham, Mai Rady, Rania M. Hathout, Mohammad Abdel-Halim, Samar Mansour
    International Journal of Pharmaceutics.2022; 629: 122387.     CrossRef
  • Cutaneous JAK Expression in Vitiligo
    Amira A. Abdel Motaleb, Yasmin M. Tawfik, Mohamed A. El-Mokhtar, Sherouk Elkady, Amira F. El-Gazzar, Suzan Kamel- ElSayed, Sara M. Awad
    Journal of Cutaneous Medicine and Surgery.2021; 25(2): 157.     CrossRef
  • Vitiligo: A focus on pathogenesis and its therapeutic implications
    Christina Bergqvist, Khaled Ezzedine
    The Journal of Dermatology.2021; 48(3): 252.     CrossRef
  • Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
    Paul Smith, Wenqing Yao, Stacey Shepard, Maryanne Covington, Jim Lee, Jennifer Lofland, Ahmad Naim, Trupti Sheth, Bhavnish Parikh, Swamy Yeleswaram
    Pharmaceutics.2021; 13(7): 1044.     CrossRef
  • Vitiligo: A Review
    Christina Bergqvist, Khaled Ezzedine
    Dermatology.2020; 236(6): 571.     CrossRef
  • Drug Repurposing Patent Applications January–March 2019
    Hermann A.M. Mucke
    ASSAY and Drug Development Technologies.2019; 17(5): 255.     CrossRef
  • Targeting the Janus Kinase Family in Autoimmune Skin Diseases
    Michael D. Howell, Fiona I. Kuo, Paul A. Smith
    Frontiers in Immunology.2019;[Epub]     CrossRef

JPTM : Journal of Pathology and Translational Medicine